OBJECTIVE
To assess the effect of Moses™ 2.0 (Lumenis Be Ltd., Yokneam Illit, Israel; Boston Scientific, Marlborough, MA, USA) for lithotripsy of renal stones of 8-20 mm in diameter on operative time, surgeon workload, and retropulsion.
SUBJECTS/PATIENTS AND METHODS
In our multicentre, randomised, double-blind clinic...
K. Maciolek, Naren Nimmagadda, A. Lee et al.· BJU International· 0 citations
PURPOSE
High-power lasers have revolutionized the treatment of stones during retrograde intrarenal surgery, but single center and retrospective studies comparing stone-free rates and efficiency of the two most commonly used modalities, pulse modulated Holmium:YAG and Thulium Fiber Laser, have had conflicting results. W...
Margaret A. Knoedler, Emily C. Serrell, Kavita Gupta et al.· Journal of Urology· 0 citations
ADI and DCI identify complementary socioeconomic disparities in nephrolithiasis, more strongly associated with categorical urine abnormalities and stone composition, whereas DCI correlated more closely with continuous urine chemistries.
Jacob M. Knorr, G. Diaz, Delaney Ryan et al.· Urology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
